The effect of imipramine-like drugs and antihistamine drugs on uptake mechanisms in the central noradrenaline and 5-hydroxytryptamine neurons.
D000639:Amitriptyline / Q000494:pharmacology; D000818:Animals; D000928:Antidepressive Agents / Q000494:pharmacology*; D001921:Brain / Q000378:metabolism*; D001977:Brompheniramine / Q000494:pharmacology; D002744:Chlorpheniramine / Q000494:pharmacology; D003891:Desipramine / Q000494:pharmacology; D003984:Dibenzazepines / Q000494:pharmacology; D004295:Dihydroxyphenylalanine / Q000494:pharmacology; D006634:Histamine H1 Antagonists / Q000494:pharmacology*; D007099:Imipramine / Q000494:pharmacology*; D008297:Male; D008856:Microscopy, Fluorescence; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D009474:Neurons / Q000187:drug effects / Q000378:metabolism; D009526:Nialamide / Q000494:pharmacology; D009638:Norepinephrine / Q000378:metabolism*; D051381:Rats; D012018:Reflex / Q000187:drug effects; D012110:Reserpine / Q000494:pharmacology; D012701:Serotonin / Q000378:metabolism*
D000928:Antidepressive Agents; D003984:Dibenzazepines; D006634:Histamine H1 Antagonists; D008996:Monoamine Oxidase Inhibitors; D000639:Amitriptyline; D012701:Serotonin; D002744:Chlorpheniramine; D004295:Dihydroxyphenylalanine; D012110:Reserpine; D001977:Brompheniramine; D007099:Imipramine; D009526:Nialamide; D003891:Desipramine; D009638:Norepinephrine